Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
Authors:
- Gerardo Santos-LópezGerardo Santos-López
- Arturo PanduroAPArturo Panduro
- Francisca Sosa-JuradoFSFrancisca Sosa-Jurado
- Nora A. FierroNora A. Fierro
- Rosalía LiraRLRosalía Lira
- Luis Márquez-DomínguezLMLuis Márquez-Domínguez
- Marco CerbónMCMarco Cerbón
- Nahum Méndez-SánchezNahum Méndez-Sánchez
- Sonia RomanSRSonia Roman
Open Access
Abstract
Viral hepatitis (A–E) presents a major global health challenge. In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis, with the aim of reducing new infections by 90% and deaths by 65% by 2030. Mexico is one of 38 focus countries identified by the WHO, collectively accounting for 80% of global infections and deaths. While hepatitis B and C are commonly diagnosed in Mexico, routine diagnosis for hepatitis D and E is lacking, with no specific epidemiological data available. In 2020, Mexico implemented the National Hepatitis C Elimination Program, focusing on preventing new infections, reducing complications like cirrhosis and hepatocellular carcinoma, ensuring access to treatment, and improving patient care. However, this program has not been extended to hepatitis B and E. Addressing the challenges of viral hepatitis control in Mexico requires increased resource allocation, expanded diagnosis, vaccination for hepatitis A and B, and treatment coverage for hepatitis B and C, along with multisectoral engagement. This work provides an overview of Mexico’s response to the global initiative, highlighting its progress, challenges, and areas of opportunity.Keywords
Funding Information
- (Consejo Estatal de Ciencias y Tecnología del Estado de Puebla), Mexico
This publication has 76 references indexed in Scilit:
- IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in MexicoAnnals of Hepatology, 2023
- Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in MexicoAnnals of Hepatology, 2022
- Hepatitis B infection in Mexican adults: Results of a nationally representative surveyAnnals of Hepatology, 2022
- A hospital-based study of the prevalence of HBV, HCV, HIV, and liver disease among a low-income population in West MexicoAnnals of Hepatology, 2022
- The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its preventionHepatology International, 2021
- A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)Annals of Hepatology, 2021
- Serological and molecular study of Hepatitis E virus in pediatric patients in MexicoAnnals of Hepatology, 2020
- Update of the statements on biology and clinical impact of occult hepatitis B virus infectionJournal of Hepatology, 2019
- First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in MexicoAnnals of Hepatology, 2019
- Is hepatitis A virus infection under control? lessons in the application of viral sequencing for the development of vaccination schemes in emergency situationsEBioMedicine, 2018